- Home
- CDNA vs SBR Comparison
CDNA vs SBR Comparison
Compare CDNA & SBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- SBR
- Stock Information
- Founded
- CDNA 1998
- SBR 1982
- Country
- CDNA United States
- SBR United States
- Employees
- CDNA N/A
- SBR N/A
- Industry
- CDNA Medical Specialities
- SBR Oil & Gas Production
- Sector
- CDNA Health Care
- SBR Energy
- Exchange
- CDNA Nasdaq
- SBR Nasdaq
- Market Cap
- CDNA 1.0B
- SBR 965.3M
- IPO Year
- CDNA 2014
- SBR N/A
- Fundamental
- Price
- CDNA $19.04
- SBR $66.18
- Analyst Decision
- CDNA Buy
- SBR
- Analyst Count
- CDNA 6
- SBR 0
- Target Price
- CDNA $30.33
- SBR N/A
- AVG Volume (30 Days)
- CDNA 996.2K
- SBR 32.1K
- Earning Date
- CDNA 07-30-2025
- SBR 01-01-0001
- Dividend Yield
- CDNA N/A
- SBR 7.69%
- EPS Growth
- CDNA N/A
- SBR N/A
- EPS
- CDNA 1.07
- SBR 5.34
- Revenue
- CDNA $346,421,000.00
- SBR $81,761,891.00
- Revenue This Year
- CDNA $13.31
- SBR N/A
- Revenue Next Year
- CDNA $15.46
- SBR N/A
- P/E Ratio
- CDNA $17.61
- SBR $12.41
- Revenue Growth
- CDNA 25.92
- SBR N/A
- 52 Week Low
- CDNA $13.48
- SBR $58.25
- 52 Week High
- CDNA $34.84
- SBR $70.20
- Technical
- Relative Strength Index (RSI)
- CDNA 55.64
- SBR 49.24
- Support Level
- CDNA $18.51
- SBR $65.75
- Resistance Level
- CDNA $19.62
- SBR $67.25
- Average True Range (ATR)
- CDNA 0.84
- SBR 1.08
- MACD
- CDNA 0.02
- SBR -0.08
- Stochastic Oscillator
- CDNA 66.12
- SBR 37.05
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About SBR Sabine Royalty Trust
Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.